Top Clinical Trials companies in France by Receivables
France
# |
Name |
Receivables |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 51.31 M
|
Dec. 31, 2023 | USD 2.01 | -0.78% |
|
France |
|
| 2 |
USD 36.10 M
|
Dec. 31, 2023 | USD 3.91 | 3.55% |
|
France |
|
| 3 |
USD 21.08 M
|
Dec. 31, 2023 | USD 5.91 | -2.66% |
|
France |
|
| 4 |
USD 17.34 M
|
Dec. 31, 2023 | USD 2.43 | 0.68% |
|
France |
|
| 5 |
USD 15.45 M
|
Dec. 31, 2023 | USD 4.22 | -0.94% |
|
France |
|
| 6 |
USD 10.48 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
| 7 |
USD 10.07 M
|
Dec. 31, 2023 | USD 21.38 K | 0.34% |
|
France |
|
| 8 |
USD 7.26 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
| 9 |
USD 5.70 M
|
Dec. 31, 2023 | USD 7.66 | 0.25% |
|
France |
|
| 10 |
USD 5.27 M
|
Dec. 31, 2023 | USD 2.03 | 3.98% |
|
France |
|
| 11 |
USD 2.43 M
|
March 31, 2024 | USD 16.83 | 1.50% |
|
France |
|
| 12 |
USD 1.94 M
|
Dec. 31, 2023 | USD 2.58 | -11.21% |
|
France |
|
| 13 |
USD 1.72 M
|
Dec. 31, 2023 | USD 2.06 | -0.75% |
|
France |
|
| 14 |
USD 260.49 K
|
Dec. 31, 2023 | USD 1.64 | 4.90% |
|
France |
|
| 15 |
USD 194.96 K
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
|
| 16 |
USD 136.82 K
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
| 17 |
USD 124.72 K
|
Dec. 31, 2023 | USD 1.39 | 1.77% |
|
France |
|
| 18 |
USD 122.52 K
|
Dec. 31, 2023 | USD 5.64 | -2.27% |
|
France |
|
| 19 |
USD 0.00
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
| 20 |
USD 0.00
|
Dec. 31, 2023 | USD 6.63 | -0.22% |
|
France |
Frequently Asked Questions
-
Which Clinical Trials company in France has the highest Receivables ?
The Clinical Trials company in France with the highest Receivables is Innate Pharma S.A. (Paris Stock Exchange: IPH.PA) at USD 51.31 M.
-
Which Clinical Trials company in France has the lowest Receivables ?
The Clinical Trials company in France with the lowest Receivables is OSE Immunotherapeutics SA (Paris Stock Exchange: OSE.PA) at USD 0.00.
-
What are the top 10 Clinical Trials companies in France by Receivables ?
The top 10 Clinical Trials companies in France by Receivables are Innate Pharma S.A., Genfit S.A., ABIVAX SA, Inventiva S.A., DBV Technologies S.A., Nanobiotix S.A., Eurofins-Cerep SA, Median Technologies SA, MaaT Pharma SA and Crossject SA.
-
What are the bottom 10 Clinical Trials companies in France by Receivables ?
The bottom 10 Clinical Trials companies in France by Receivables are OSE Immunotherapeutics SA, Affluent Medical SA, Adocia SA, Valbiotis SA, Novacyt S.A., Predilife S.A., AB Science S.A., Advicenne S.A., Aelis Farma SA and MedinCell S.A..
